Clinical Trial Support and Patient Identification
Utilize Ambry’s specialized genetic testing and interpretation, extensive field outreach, and robust clinical research database to address challenges in patient identification and trial enrollment.
Optimizing the Clinical Trial Lifecycle
Whether launching a precision medicine study or supporting ongoing on-market programs, appropriate patient identification and enrollment in clinical trials are critical milestones. Ambry offers targeted patient identification strategies with robust quality assurance, project management, and regulatory support to help streamline clinical trials.
- Patient Identification: Leverage pharma services genetic testing panels, expert variant interpretation, and a clinical research database of over 2.5 million tests to locate and enroll patients, particularly within rare disease populations.
- Project Management: Bring operational rigor across your trial with dedicated project management, regulatory support, and quality assurance that follows strict Good Clinical Laboratory Practice (GCLP) standards.
- Field Outreach: Raise patient/provider awareness of your study by leveraging our established field outreach networks to increase trial enrollment, while delivering deep clinical insights through comprehensive reports.
Contact us to learn more about AmbryLink sponsored testing programs.
Multiple test ordering modalities are available to lower barriers to testing, integrating into provider workflows via physical Test Requisition Forms, AmbryPort (online ordering portal), and EMR integration.
We can also partner with you for commercial activities, including marketing outreach for patients and providers, field team engagement with providers, and other operational needs such as genetic counseling services, test ordering/kit distribution, and program utilization reporting.
Informing Pipeline Decisions with Advanced Insights
Ambry applies Classifi, our scientific expertise and approach, to dive deeper and transform patient results into structured, actionable insights that advance clinical objectives:
- Comprehensive Clinical Resources: High-quality reporting and accurate, accessible clinical resources that empower investigators and patients to understand and share test results.
- Targeted Communications: Sharing clinical trial opportunities with appropriate healthcare providers, explaining study relevance and how patients can learn about trial enrollment.
- Program Metrics: Weekly or monthly data summaries to pharmaceutical partners to track test volumes, number of ordering providers, positivity rates, and mutation profiles to keep teams updated on progress.